Hindustan Unilever Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 4 Aug 2026 | Diversified FMCG | Market Cap: ₹4.9L Cr
FY'27 revenue expected to be better than FY'26; guidance maintained for margin within range (Niranjan Gupta). FY'27 top line is expected to be better than FY'26, with growth remaining the number one priority (Niranjan Gupta).
From Hindustan Unilever Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹2,015
Market Cap
₹4.9L Cr
P/E Ratio
44.3
How does Hindustan Unilever Ltd rank in Diversified FMCG?
Compare Hindustan Unilever Ltd against every Diversified FMCG company this quarter on revenue, margins and earnings-call signals.
Hindustan Unilever Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹16.4K Cr, net profit ₹3.0K Cr.
Full financials →📊 Revenue & Sales Performance
- →FY'27 revenue expected to be better than FY'26; guidance maintained for margin within range (Niranjan Gupta).
- →Second half of FY'26 anticipated to be better than first half, indicating improving momentum (Priya Nair).
- →Growth priority is volume-led, supported by scale efficiencies and investments in growth areas (Niranjan Gupta).
- →Highest ever Underlying Volume Growth (UVG) in 12 quarters recorded recently, reflecting broad-based improvement across categories (Priya Nair).
- →Consumer sentiment and macro conditions improving, supporting consumption growth in both rural and urban areas (Niranjan Gupta).
- →Quick commerce channel rapidly scaling, expected to meaningfully grow, contributing to incremental demand (Niranjan Gupta).
- →Portfolio transformation towards premiumization and high-growth categories ongoing to boost growth (Priya Nair).
- →Overall volume growth around 4% recently, with optimistic outlook supported by internal green shoots and improving elasticity (Priya Nair).
📈 Profitability & Margins
- →FY'27 top line is expected to be better than FY'26, with growth remaining the number one priority (Niranjan Gupta).
- →Growth will be volume-led, supported by scale efficiencies and operating leverage, while maintaining price-value competitiveness (Niranjan Gupta).
- →EBITDA margins are expected to stay within the guided range, with reinvestments to support growth (Niranjan Gupta).
- →Double-digit earnings growth is guided, supported by low single-digit pricing growth and sustained volume growth (Mihir P Shah and Niranjan Gupta).
- →Broader economic improvements and internal strategic actions are expected to drive growth and operating performance (Priya Nair, Niranjan Gupta).
- →Investments in R&D, agility, and India-centric innovations are expected to enhance speed and relevance, supporting growth (Priya Nair).
- →Overall, the outlook balances accelerated growth with disciplined margin management for sustained profit growth.
🏗️ Capital Expenditure Plans
- →Hindustan Unilever Limited (HUL) is continuing to invest behind growth, including brand investments and A&P, with absolute A&P increasing by approximately Rs. 200 crores year-on-year and expected to step up as needed.
- →The company is scaling its presence in fast-growing segments like Masstige and D2C channels, notably doubling down on brands like OZiva with full acquisition (remaining 49% stake) for Rs. 824 crores, signaling strategic investment in Health & Wellbeing.
- →Investments are also being made in quick commerce, a high-growth channel contributing ~3% of the business, with a dedicated organization established to accelerate growth.
- →HUL is focusing on technology and R&D with the creation of an India-focused R&D category design and deploy organization to enhance speed, agility, and customization for the Indian market.
- →Capital deployment also includes portfolio reshaping by divesting non-core assets (e.g., selling minority stake in Nutritionalab for Rs. 307 crores).
💰 Fundraising & Capital Structure
- →The transcript does not mention any current or planned fundraising activities through debt or equity by Hindustan Unilever Limited.
- →There is no discussion of new debt issuances or equity offerings in the December Quarter 2025 earnings call.
- →The company mentions continuing to invest in business growth and strategic priorities, but no specific fundraising plans are disclosed.
- →The focus appears to be on internal cash flows and existing financial resources, including investing in acquisitions like increasing stake in OZiva, without mention of raising capital externally.
- →No commentary on leveraging the balance sheet further or engaging in capital markets for fundraising is provided.
📋 Order Book & Pipeline
Key Metrics
Continue your research
What Hind. Unilever's management said in earlier quarters
Others in Diversified FMCG this season
- Godavari Biorefineries Ltd (Q3 FY26)
Continued cost optimization, improved product mix, and operating leverage led to a 13.8% EBITDA growth in Q3 FY26, with margins improving by 97 bps to 9.8%…
- Hindustan Foods (Q3 FY26)
Approximately INR 200 crores of capital is yet to be ramped up or underutilized, with additional capital work in progress (CWIP) and advances. Key concall…
Frequently Asked Questions
What were Hindustan Unilever Ltd Q3 FY26 results?
FY'27 revenue expected to be better than FY'26; guidance maintained for margin within range (Niranjan Gupta). FY'27 top line is expected to be better than FY'26, with growth remaining the number one priority (Niranjan Gupta).
What is Hindustan Unilever Ltd share price analysis?
Hindustan Unilever Ltd currently shows a neutral. The stock trades at a P/E of 44.2 with a market cap of ₹488,010 Cr. Investors should review the full earnings analysis for detailed insights.
Is Hindustan Unilever Ltd planning capital expenditure?
Hindustan Unilever Limited (HUL) is continuing to invest behind growth, including brand investments and A&P, with absolute A&P increasing by approximately Rs.
Keep Hindustan Unilever Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.